First Washington Corp Orasure Technologies Inc Transaction History

First Washington Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$2.71 - $7.12 $2,850 - $7,490	-1,052 Reduced 0.45%	233,268 $632,000
Q1 2022 May 11, 2022	BUY	$6.62 - $9.33 $35,039 - $49,383	5,293 Added 2.31%	234,320 $1.59 Million
Q4 2021 Feb 10, 2022	SELL	$8.3 - $11.29 $20,608 - $28,033	-2,483 Reduced 1.07%	229,027 $1.99 Million
Q4 2020 Feb 11, 2021	SELL	$10.35 - $15.94 $27,531 - $42,400	-2,660 Reduced 1.14%	231,510 $2.45 Million
Q3 2020 Nov 13, 2020	BUY	$10.24 - $19.58 $132,198 - $252,777	12,910 Added 5.83%	234,170 $2.85 Million
Q2 2020 Aug 13, 2020	BUY	$9.71 - $17.87 $2.15 Million - $3.95 Million	221,260 New	221,260 $2.57 Million
Q4 2018 Feb 08, 2019	SELL	$10.53 - $15.54 $2.57 Million - $3.79 Million	-244,020 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$15.25 - $17.72 $7,625 - $8,860	-500 Reduced 0.2%	244,020 $3.77 Million
Q1 2018 May 04, 2018	SELL	$16.77 - $22.04 $164,010 - $215,551	-9,780 Reduced 3.85%	244,520 $4.13 Million
Q4 2017 Feb 07, 2018	BUY	$13.44 - $22.81 $3.42 Million - $5.8 Million	254,300	254,300 $4.8 Million

202

65.5M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $277M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of First Washington Corp, based on Form 13F filings with the SEC.

Stay updated on First Washington Corp with notifications on news.